 |
|
Impact of imatinib administration on the mouse ovarian follicle count and levels of intra-ovarian proteins related to follicular quality
Se Jeong Kim, Tae Eun Kim, Byung Chul Jee
Clin Exp Reprod Med. 2022;49(2):93-100. Published online 2022 May 30 DOI: https://doi.org/10.5653/cerm.2022.05218
|
|
Citations to this article as recorded by
 Can we really protect the ovary from chemotherapy damage?
Thuy Truong An Nguyen, Margherita Condorelli, Isabelle Demeestere
Best Practice & Research Clinical Obstetrics & Gyn.2025; 99: 102603. CrossRef Gynotoxic Effects of Chemotherapy and Potential Protective Mechanisms
Anna Markowska, Michał Antoszczak, Janina Markowska, Adam Huczyński
Cancers.2024; 16(12): 2288. CrossRef Melatonin partially rescues defects induced by tranexamic acid exposure during oocyte maturation in mice
Fei Chen, Mengyao Zhang, Zihan Song, Rui Meng, Jiayi He, Xiuli Xu, Shuwen Deng, Meng Sun, Zhenyu Kou, Juan Lin
American Journal of Physiology-Cell Physiology.2024; 327(3): C778. CrossRef Overactivation or Apoptosis: Which Mechanisms Affect Chemotherapy-Induced Ovarian Reserve Depletion?
Oren Kashi, Dror Meirow
International Journal of Molecular Sciences.2023; 24(22): 16291. CrossRef Chemotherapy-induced ovarian damage and protective strategies
Peikun Zhao, Chenxi Guo, Huijia Du, Yuan Xiao, Jiaping Su, Xiaohui Wang, Willian S. B. Yeung, Guangxin Li, Tianren Wang
Human Fertility.2023; 26(4): 887. CrossRef
|